AYTU BIOPHARMA, INC (AYTU)
CIK 1385818 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 10.7M shares as of Apr 30, 2026 (10-Q). Share count fell from 62.4M to 3.1M between Sep 19, 2022 and Nov 9, 2022, a pattern consistent with a reverse split (roughly 1-for-20); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Self-funding
generates cash
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Pre Funded Warrants | 8.8M | $0.0001 | — | — |
| Amended2025 Prefunded Warrants | 6.7M | $0.0001 | — | — |
| Warrants Excluding Prefunded Warrants | 3.8M | $4.17 | 2.6y | — |
| Liability Warrants | 2.2M | not tagged | — | — |
| Amended2023 Prefunded Warrants | 2.1M | $0.0001 | — | — |
| Amended2023 Tranche A Warrants | 1.6M | $1.59 | 2.2y | — |
| Equity Warrants | 1.6M | not tagged | — | — |
| March2022 Warrants | 1.2M | $2.32 | 1.6y | — |
| June2023 Tranche A Warrants | 543,478 | $1.59 | 2.2y | — |
| June2023 Tranche A Warrants Liability Classified | 543,478 | not tagged | — | — |
| January2022 Warrants | 333,300 | $26 | 1.4y | — |
| December2020 Warrants | 122,092 | $8.6 | 0.8y | — |
Tranches exactly as the company dimensioned them in its 10-Q filed May 13, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 12.6M underlying shares, as reported Mar 31, 2026 (10-Q).
Reported exercise price: $0.0001 (aggregate figure as tagged; individual tranches vary).
Balance-sheet fair value of warrants: $400,000 as of Mar 31, 2022.
Rough fully diluted estimate: 23.4M = 10.7M O/S + 12.6M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
No convertible-note facts tagged in the 10-Q filed May 13, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 10.7M | Apr 30, 2026 |
| + Pre Funded Warrants (if exercised) | 8.8M | Mar 31, 2026 |
| + Amended2025 Prefunded Warrants (if exercised) | 6.7M | Mar 31, 2026 |
| + Warrants Excluding Prefunded Warrants (if exercised) | 3.8M | Mar 31, 2026 |
| + Liability Warrants (if exercised) | 2.2M | Mar 31, 2026 |
| + Amended2023 Prefunded Warrants (if exercised) | 2.1M | Mar 31, 2026 |
| + Amended2023 Tranche A Warrants (if exercised) | 1.6M | Mar 31, 2026 |
| + Equity Warrants (if exercised) | 1.6M | Mar 31, 2026 |
| + March2022 Warrants (if exercised) | 1.2M | Mar 31, 2026 |
| + June2023 Tranche A Warrants (if exercised) | 543,478 | Mar 31, 2026 |
| + June2023 Tranche A Warrants Liability Classified (if exercised) | 543,478 | Mar 31, 2026 |
| + January2022 Warrants (if exercised) | 333,300 | Mar 31, 2026 |
| + December2020 Warrants (if exercised) | 122,092 | Mar 31, 2026 |
| Fully diluted estimate | 40.4M | +276.0% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Last 12 months: 1 executed · 0 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full AYTU workspace